Jean-Marc Guedon
Jean-Marc has been working on viral vector process development throughout his career. At Janssen, he contributed to health authority filings for 2 CAR-T therapeutics through Read more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok